Joshua R. Dower, MD
Hematology Oncology PC
Stamford, CT 06904
Main: 203.276.2695
Fax: 203.975.7842
About Me
Dr. Joshua Dower completed his training in hematology and medical oncology at Tufts Medical Center in Boston. He chose to specialize in this field given its constant growth and innovation, allowing for new and improved treatments that lead to better outcomes. Dr. Dower enjoys working with patients and their loved ones to develop the best, individualized treatment plan to help combat their specific disease. He strives to always be available to patients and their families as they navigate through difficult times.
Dr. Dower grew up in New Jersey and is excited to join Hematology Oncology Associates. In his free time, he enjoys traveling, relaxing at the beach, and cooking with his wife.
-
Specialties
Specialties
Hematology
Internal Medicine
Medical OncologySpecial Interests
Languages
English
Spanish -
Education & Training
Medical School
Tufts University School of Medicine
Residency
Tufts Medical Center
Fellowship
Tufts Medical Center
Undergraduate
Tufts University
-
Board Certifications & Affiliations
Board Certifications
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Medical Oncology
American Board of Internal Medicine - Internal MedicineAffiliations
American Society of Clinical Oncology
American Society of Hematology
Published Work
Dower, J., Salei, Y., Koethe, B., Julian, A., Schwartz, J., Dumas, B., Elkon, J.M., Buchsbaum, R.J., & Schlam, I.
Tolerability, dose intensity, and prescribing patterns of capecitabine by race. J Clin Oncol 42,
2024 (suppl 16; abstr e23278).
Schlam I., Dower J., Lynce F. Addressing residual disease in HER2-Positive and triple-negative breast cancer:
What is next? Current Oncology Reports. 2024, DOI: 10.1007/s11912-024-1501-0.
Markouli M., Ullah F., Omar, N., Apostolopoulou A., Dhillon P., Panagiotis D., Dower J., Gurnari C., Ahmed S.,
& Dima D. Recent advances in adult post-transplant lymphoproliferative disorder. Cancers. 2022,
14(23):5949. DOI: 10.3390/cancers14235949.
Dower J., Dima D., Lalla M., Patel A., Comenzo R., & Varga C. The use of PYP scan for evaluation of ATTR
cardiac amyloidosis at a tertiary medical center. The British Journal of Cardiology. 2022, 29: 73-6.
DOI: 10.5837/bjc.2022.019.
Dima D., Hu X., Dower J., Zhang D., Comenzo R., & Varga C. Pattern of use and efficacy of daratumumab-
based therapy in patients with relapsed/refractory light chain amyloidosis in a real-world setting: a
single institution experience. Leukemia & Lymphoma. 2022, 5:1246-50. DOI:
10.1080/10428194.2021.2018585.
Dima, D.*, Dower, J.*, Varga, C., & Comenzo, R. Evaluating daratumumab in the treatment of multiple
myeloma: safety, efficacy and place in therapy. Cancer Management and Research. 2020, 12:7891-
903. DOI: 10.2147/CMAR.S212526. *Co-First Author.
Dower, J.*, Song, F.*, Sun, D.Y.*, & Buchsbaum, R. Along the road to quality in cancer care. Quality Measures. 2020, pp 85-98. *Co-First Author.
Mao, D., Hachem, H., Chang, H., Dima, D., Dower, J., Wismer, M., Erban, J.K., Freund, K.M., & Parsons, S.K. Treatment interruption and discontinuation of hormonal therapy in hormone receptor-positive breast cancer patients. Breast Cancer Research and Treatment. 2020, 184(3): 665-74. DOI: 10.1007/s10549-020-05892-z.
Dower, J.*, Dima, D.*, Seiker, J., Pilichowska, M., & Varga, C. Eculizumab-induced late erythroid maturation arrest: a case report. British Journal of Haematology. 2020, 191(1); 120-2. DOI: 10.1111/bjh.16936. *Co-First Author.
Hachem, H., Dima, D., Dower, J., Levitz, D., Wismer, M., & Parsons, S.K. Contemporary use of inpatient antineoplastic (IP) treatment (Rx): who is getting care and why? Journal of Clinical Oncology. 2019, 37: 15_supp, e18015-e18015. DOI:10.1200/JCO.2019.37.15_supp.e18015.
If You Are in Need of Emergency Care, Call 911.
The majority of the physicians on the Stamford Hospital Medical Staff are not employees or agents of the Hospital. They are independent practitioners who have been granted the privilege of using the Hospital's facilities for the care and treatment of their patients. This includes, but is not limited to, emergency department physicians, anesthesiologists, radiologists, surgeons, cardiologists, obstetricians, pathologists and other consultants who may treat patients.
Insurance listings are subject to change at any time. Please verify insurance plan acceptance when scheduling an appointment with a healthcare provider.